NCT05718895
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05718895
Title A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors (CLINCH)
Acronym CLINCH
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Antengene Biologics Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Cancer Research SA Pty Ltd COMPLETED Adelaide Australia Details
Cabrini Health Limited RECRUITING Malvern Australia Details
Integrated Clinical Oncology Network Pty Ltd (Icon) RECRUITING South Brisbane Australia Details
West China Hospital, Sichuan University RECRUITING Chengdu China Details
Fujian Cancer Hospital RECRUITING Fuzhou China Details
Jinan Central Hospital RECRUITING Jinan China Details
Gansu provincial cancer hospital [recruiting] RECRUITING Lanzhou China Details
The Affiliated Hospital of Qingdao University RECRUITING Qingdao China Details
Fudan University Shanghai Cancer Center RECRUITING Shanghai China Details
Tongren Hospital Shanghai RECRUITING Shanghai China Details
Liaoning Cancer Hospital RECRUITING Shenyang China Details
The Fourth Hospital of Hebei Medical University RECRUITING Shijiangzhuang China Details
Shanxi provincial cancer hospital RECRUITING Taiyuan China Details
Hubei Cancer Hospital RECRUITING Wuhan China Details
The First affiliated hospital of Xi'An Jiao Tong Ubiversity RECRUITING Xi'an China Details
Xuzhou Central Hospital RECRUITING Xuzhou China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field